National Health Investors (NHI) FY2018 results: revenue $295 million, up 5.7% on the year
National Health Investors Inc. (NHI) reported revenue of $295 million for fiscal 2018, the year ended 31 December 2018, up 5.7% on the year before. Net income was $154 million, down 3.2%, and diluted earnings per share $3.67. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2019.
Revenue
$295 million
+5.7% on the year
FY2011FY2018
Operating margin
52.6%
54.4% a year earlier
FY2011FY2018
Net income
$154 million
-3.2% on the year
FY2011FY2018
Diluted EPS
$3.67
-5.2% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
295
279
248
+5.7%
Operating income
155
151
119
+2.4%
Operating margin
52.6%
54.4%
47.8%
Interest expense
49.1
46.3
43.1
+5.9%
Pre-tax income
155
151
119
+2.4%
Income tax
0.1
0.1
0.9
+11.3%
Effective tax rate
0.1%
0.1%
0.7%
Net income
154
159
152
-3.2%
Net margin
52.4%
57.2%
61.0%
Diluted EPS
$3.67
$3.87
$3.87
-5.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
208
198
177
+4.9%
Capital expenditure
148
176
395
-16.0%
Free cash flow
60.2
22.3
-218
+170.0%
Free cash flow margin
20.4%
8.0%
-87.8%
Cash from investing
-250
-164
-330
Cash from financing
44.3
-35.1
144
Share-based compensation
2.5
2.6
1.7
-4.7%
Dividends paid
165
153
138
+8.1%
Dividend per share
$4.00
$3.80
$3.60
+5.3%
Diluted shares, weighted
42m
41m
39m
+2.3%
Shares outstanding at period end
43m
42m
40m
+2.8%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
1,390
1,322
1,210
+5.1%
Non-controlling interest
0.0
n/a
0.0
Debt
1,282
1,145
1,116
+11.9%
Other liabilities
79.2
78.2
78.1
+1.2%
Total liabilities and equity
2,751
2,546
2,404
+8.0%
Fixed assets
2,367
2,286
2,160
+3.6%
Loans
246
141
133
+73.9%
Cash and equivalents
4.7
3.1
4.6
+52.1%
Receivables
6.4
2.4
9.2
+162.7%
Other assets
127
113
96.5
+11.8%
Total assets
2,751
2,546
2,404
+8.0%
10-K for the year ended 31 December 2018, filed 19 February 2019: the filing.